Search:
Scroll to top
Tag: digital therapeutics
03/22/2023

Digital Health Tech: A Solution to Substance Use Disorders?

Article Excerpt: Healthcare is turning towards tech to develop effective therapies for substance use disorders
While there are several well-established pharmaceutical treatment options available for smoking cessation, and for opioid and alcohol use disorders, there is still a high demand for more effective therapies. According to GlobalData’s Medical Device Pipeline Analytics, there are 61 products in development for treating substance abuse disorders classed as healthcare IT.

Full Article: https://tinyurl.com/3unbwpmh

Article Source: Medical Device Network

Posted in: Emerging Technologies // Tagged: ; ; ; ; ; ; ;
03/08/2023

Cognitive Behavioral Therapy Mobile App Improves Health Behavior in Patients with Diabetes

Article Excerpt: With the use of cognitive behavioral therapy, a smartphone app helped patients with type 2 diabetes reduce HbA1c with less medication and insulation intensification vs. controls, a speaker reported. “Cardiometabolic diseases, and at its core, type 2 diabetes, are largely behavioral-acquired diseases and they’re related to unhelpful behaviors. But when we drive to what are the core, root causes of these behavioral choices, they have to do with thoughts and beliefs that lead to unhelpful behaviors and then unhelpful food choices, eating, exercise or behaviors and then type 2 diabetes,” Marc P. Bonaca, MD, MPH, FAHA, FACC, executive director of CPC Clinical Research, professor of cardiology and vascular medicine and director of vascular research at the University of Colorado School of Medicine, said during a press conference. “How do we break that cycle?

Full Article: https://tinyurl.com/2s4ht3rj

Article Source: Healio

Posted in: Emerging Technologies // Tagged: ; ; ; ; ; ;
03/07/2023

Psychological Phenotypes Correlate with Response to Digital Therapy for Anxiety

Article Excerpt: A patient’s psychological phenotype could be an indication of whether the patient will respond to a digital therapy for anxiety, according to a new report. The study offers insights that could help clinicians offer personalized care to patients with psychological conditions, but it also could explain why some patients respond more strongly than others to the types of therapy often leveraged by prescription digital therapeutics. The findings were published in Scientific Reports. Corresponding author Veronique A. Taylor, Ph.D., M.Sc., of the Brown University School of Public Health, and colleagues, said while personalized medicine has become an important component of other types of healthcare, personalized medicine in mental health has lagged due in part to a lack of research.

Full Article: https://tinyurl.com/2p8tnr2j

Article Source: Managed Healthcare Executive

Posted in: Methodologies & Analytics, Uncategorized // Tagged: ; ; ; ; ; ; ;
01/29/2023

With Digital Therapeutics, You Can Design Your Health

Article Excerpt: Digital health has emerged as a go-to-by thing during the last decade thanks to smart phones, mobile applications, wearable devices, cloud-based data platforms, social media platforms, and the like. The result is, that unlike the past, today’s patients… now have the freedom to participate in their own treatment decisions.

Full Article: https://tinyurl.com/4w8dfxhz

Article Source: ETHealthworld

Posted in: Emerging Technologies // Tagged: ; ; ; ; ;
12/20/2022

Bill Could Pave the Way for Prescription Digital Therapeutics Reimbursement

Article Excerpt: New legislation would allow for reimbursement of prescribed digital therapeutics under Medicare, which proponents argue could increase access to these emerging treatments. Still, others say it’s new technology, and the wrong reimbursement model could tamper innovation and increase patient costs. The Access to Prescription Digital Therapeutics Act of 2022, introduced in the U.S. Senate in March, aims to amend the Social Security Act to provide Medicare coverage and reimbursement for prescription digital therapeutics.

Full Article: https://tinyurl.com/464yhtr7

Article Source: MobiHealthNews

Posted in: Regulation & Policy // Tagged: ; ; ; ;
12/05/2022

Book Chapter Sneak Peak: Introduction And Aims of Digital Therapeutics for Mental Health and Addiction

Article Excerpt: In this first chapter, the book’s editors Jacobson, Kowatsch and Marsch “introduce a comprehensive overview of the field of digital therapeutics and research on their efficacy, effectiveness, scalability, and cost-effectiveness (pp. 1).” The authors are looking to introduce the topic of digital therapeutics to a broad audience and designed this book for people without a background in mental health or substance use. The authors’ vision includes conveying how advancements in technology can be leveraged to increase the effectiveness of interventions. Topics relating to structural considerations include the design of interventions, cultural adaptations, regulation, and data privacy.

Full Article: https://tinyurl.com/56jdnyae

Article Source: Centre for Digital Health Interventions News

Posted in: Dissemination & Implementation // Tagged: ; ; ; ; ; ; ;
11/10/2022

Digital Therapeutics Summit Held at Dartmouth

Article Excerpt: Nearly 175 people representing the digital health and pharmaceutical industries, health care systems, clinicians, scientists, investors, Dartmouth students and faculty, and government officials representing the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) gathered on Dartmouth’s campus November 2 for daylong discussions centered on digital therapeutics. Hosted by Geisel School of Medicine’s Center for Technology and Behavioral Health (CTBH) and Dartmouth’s Magnuson Center for Entrepreneurship, the program provided an overview of the science and clinical practice of digital therapeutics, the current and anticipated paths to their global deployment, and a vision for the future. This is the first time these groups have come together in conversations hosted by an academic institution about the digital health landscape and may well be viewed as a seminal moment in the rapidly developing field.

Full Article: https://tinyurl.com/2fnhbyxa

Article Source: Dartmouth Geisel School of Medicine News

Posted in: Dissemination & Implementation // Tagged: ; ; ; ; ; ; ; ; ; ;
11/08/2022

Register for Dartmouth Accelerator for Digital Health

Article Excerpt: DIADH, a partnership between the Center for Technology and Behavioral Health and the Magnuson Center for Entrepreneurship will help translate digital therapeutics and digital health innovations developed at Dartmouth into the marketplace. Registration to participate in DIADH is now open at https://www.c4tbh.org/accelerator/register. Dartmouth students, staff and faculty working to bring novel digital therapeutics and digital health tools to market will soon have a new resource available to them: the Dartmouth Innovation Accelerator for Digital Health (DIADH). The Accelerator was announced last week at “Clinically Validated Digital Therapeutics: Paths to Deployment,” an international summit hosted in Hanover by the Center for Technology and Behavioral Health (CTBH), an NIH-recognized National Center of Excellence within the Geisel School of Medicine at Dartmouth, and the Magnuson Center for Entrepreneurship at Dartmouth. The Summit brought together players from across the healthcare industry — including providers, payers, researchers, developers, regulators, and investors — for the first time to discuss the future of digital therapeutics and digital health. This is an area of healthcare that encompasses any software used to prevent, treat, or manage a medical disorder or disease. In addition, several Dartmouth faculty members who are affiliated with CTBH described the exciting work that is being at Dartmouth to bring world-class science to this important new area of healthcare. “There was a focus on problem solving and removing barriers in the industry so that we can accelerate the impact of digital health tools on people’s lives,” says Lisa A. Marsch, Ph.D., Director of CTBH.

Full Article: https://tinyurl.com/493eb29m

Article Source: Vox Daily

Posted in: Dissemination & Implementation, Emerging Technologies // Tagged: ; ; ; ; ; ;
10/31/2022

Digital Health Summit Brings Together Leaders In Digital Therapeutics

Article Excerpt: Players from across the healthcare industry — including providers, payers, researchers, regulators and investors — will converge on Hanover Wednesday, November 2 for a digital health summit entitled “Clinically Validated Digital Therapeutics: Paths to Deployment.” The event, hosted by the Center for Technology and Behavioral Health (CTBH) and The Magnuson Center for Entrepreneurship at Dartmouth College, will cover the current state of digital therapeutics, and explore the paths to global deployment of this innovative type of healthcare. “We have a community, here at Dartmouth, that’s very well known for expertise in digital therapeutics,” says Lisa A. Marsch, Ph.D., Director of CTBH. CTBH is a nationally recognized Center of Excellence, funded by the National Institute on Drug Abuse.

Full Article: https://tinyurl.com/mryf2uvj

Article Source: The Magnuson Center Blog

Posted in: Dissemination & Implementation // Tagged: ; ; ; ;